Insuman Rapid 100unitsml solution for injection 3ml pre-filled OptiSet pen

Country: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Insulin soluble human

থেকে পাওয়া:

Sanofi

এটিসি কোড:

A10AB01

INN (International Name):

Insulin soluble human

ডোজ:

100unit/1ml

ফার্মাসিউটিকাল ফর্ম:

Solution for injection

প্রশাসন রুট:

Subcutaneous

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

VMP not recommended to prescribe - patient training required

পণ্য সারাংশ:

BNF: 06010101; GTIN: 5013011004733

পণ্য বৈশিষ্ট্য

OBJECT 1
INSUMAN RAPID 100 IU/ML SOLUTION FOR INJECTION
IN A CARTRIDGE
Summary of Product Characteristics Updated 13-Apr-2018 | SANOFI
1. Name of the medicinal product
Insuman Rapid 100 IU/ml solution for injection in a cartridge
2. Qualitative and quantitative composition
Insuman Rapid 100 IU/ml in a cartridge
Each ml contains 100 IU insulin human (equivalent to 3.5 mg).
Each cartridge contains 3 ml of solution for injection, equivalent to
300 IU insulin.
One IU (International Unit) corresponds to 0.035 mg of anhydrous human
insulin
*
.
Insuman Rapid is a neutral insulin solution (regular insulin).
*
Human insulin is produced by recombinant DNA technology in
_Escherichia coli_.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for injection.
Clear, colourless solution.
4. Clinical particulars
4.1 Therapeutic indications
Diabetes mellitus where treatment with insulin is required.
4.2 Posology and method of administration
Posology
The desired blood glucose levels, the insulin preparations to be used
and the insulin dose regimen (doses
and timings) must be determined individually and adjusted to suit the
patient's diet, physical activity and
life-style.
_Daily doses and timing of administration _
There are no fixed rules for insulin dose regimen. However, the
average insulin requirement is often 0.5
to 1.0 IU per kg body weight per day. The basal metabolic requirement
is 40% to 60% of the total daily
requirement. Insuman Rapid is injected subcutaneously 15 to 20 minutes
before a meal.
_Secondary dose adjustment _
Improved metabolic control may result in increased insulin
sensitivity, leading to a reduced insulin
requirement. Dose adjustment may also be required, for example, if
- the patient's weight changes,
- the patient's life-style changes,
- other circumstances arise that may promote an increased
susceptibility to hypo- or hyperglycaemia (see
section 4.4).
_Special populations _
_Elderly population(_
_65 years old)_
≧
In the elderly, progressive deterioration of renal function